Five3 Genomics, LLC – Trademark Portfolio
Entity Type: 16
Five3 Genomics, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TRANSPORTER. The owner is based in Culver City, CA.
9920 Jefferson Boulevard
Culver City, CA 90232
Showing of trademarks Trademarks
Trademark Classifications
Five3 Genomics, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Five3 Genomics, LLC have?
Five3 Genomics, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 5 cancelled.
What trademark classes does Five3 Genomics, LLC file in?
Five3 Genomics, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Five3 Genomics, LLC's most well-known trademarks?
Five3 Genomics, LLC's registered trademark portfolio includes well-known marks such as TRANSPORTER. These are among 1 currently registered trademark in the portfolio.
What is Five3 Genomics, LLC's trademark registration success rate?
Five3 Genomics, LLC has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.